journal article·2014-03-26

Oligonucleotides—Assembled Au Nanorod-Assisted Cancer Photothermal Ablation and Combination Chemotherapy with Targeted Dual-Drug Delivery of Doxorubicin and Cisplatin Prodrug

Vijayakumar Shanmugam, Yi-Hsin Chien, Yu-Sheng Cheng, Tzu-Yu Liu, Chih-Chia Huang, Chia-Hao Su, Yu-Sen Chen, Umesh Kumar, Hua-Fen Hsu, Chen-Sheng Yeh

Publisher page

Abstract

External stimuli responsive dual drugs carrier was synthesized with Au nanorods (NRs) as the platform. On Au NRs, single stranded DNAs were assembled using 5' thiol end. Following this, complementary DNA (cDNA) strands were hybridized. This hybridized double stranded DNA facilitated doxorubicin (Dox) intercalation into the duplexes. The cDNA designed with the 5' amine functional group assisted to tether platinum [Pt(IV)] prodrugs by establishing amide bond with the acid group at the axial ligand. The other axial acid group in Pt(IV) prodrugs was conjugated with the folic acid (FA) to target folate receptors overexpressed in the cancer cells. This targeting vehicle provided remote-controlled delivery of this high toxic cargo cocktail at the tumor site, ensuring extra specificity that can avoid acute toxicity, where release of Dox and Pt(IV) was achieved upon NIR 808 nm diode laser irradiation. The dehybridization set the Dox free to bind the cell nucleus and cellular reductants reduced Pt(IV) to yield toxic Pt(II), becoming an active drug. The in vitro and in vivo studies revealed that this external stimulus responsive combination drug delivery was significantly effective.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced biosensing and bioanalysis techniques · Gold and Silver Nanoparticles Synthesis and Applications · Nanocluster Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemistry, Center for Micro/Nano Science and Technology, and Advanced Optoelectronic Technology Center, National Cheng Kung University, Tainan 701, Taiwan

Department of Applied Chemistry, National University of Kaohsiung, Kaohsiung 811, Taiwan

Center for Translational Research in Biomedical Sciences, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan

Department of Chemistry, National Cheng Kung University, Tainan 701, Taiwan

References (38)

Show source-provided references
1. Jia J. · Nat. Rev. Drug Discovery · 2009 · 8 · 11110.1038/nrd2683 ↗
2. Lehár J. · Nat. Biotechnol. · 2009 · 27 · 65910.1038/nbt.1549 ↗
3. Lee J. · Cancer Chemother. Pharmacol. · 2004 · 54 · 38510.1007/s00280-004-0837-7 ↗
4. Thigpen J. T. · J. Clin. Oncol. · 2004 · 22 · 390210.1200/JCO.2004.02.088 ↗
5. Aapro M. S. · Ann. Oncol. · 2003 · 14 · 44110.1093/annonc/mdg112 ↗
6. Nielsen D. · Cancer Chemother. Pharmacol. · 2000 · 46 · 45910.1007/s002800000178 ↗
7. Martoni A. · Oncology · 1989 · 46 · 10910.1159/000226696 ↗
8. Wang X. · PLoS One · 2013 · 8 · e7394210.1371/journal.pone.0073942 ↗
9. Hu C. M. · Ther. Delivery · 2010 · 1 · 32310.4155/tde.10.13 ↗
10. Davis M. E. · Nat. Rev. Drug Discovery · 2008 · 7 · 77110.1038/nrd2614 ↗
11. Peer D. · Nat. Nanotechnol. · 2007 · 2 · 75110.1038/nnano.2007.387 ↗
12. Lee S.-M. · J. Am. Chem. Soc. · 2010 · 132 · 1713010.1021/ja107333g ↗
13. Kolishettia N. · Proc. Natl. Acad. Sci. U. S. A. · 2010 · 107 · 1793910.1073/pnas.1011368107 ↗
14. Shuhendler A. J. · Breast Cancer Res. Treat. · 2010 · 119 · 25510.1007/s10549-008-0271-3 ↗
15. Wang H. · Biomaterials · 2011 · 32 · 828110.1016/j.biomaterials.2011.07.032 ↗
16. Singh A. · ACS Appl. Mater. Interfaces · 2011 · 3 · 84210.1021/am101196v ↗
17. Kim D. · ACS Nano · 2010 · 4 · 368910.1021/nn901877h ↗
18. Bagalkot V. · Angew. Chem., Int. Ed. · 2006 · 45 · 814910.1002/anie.200602251 ↗
19. Frederick C. A. · Biochemistry · 1990 · 29 · 253810.1021/bi00462a016 ↗
20. Hurst S. J. · Anal. Chem. (Washington, DC, U. S.) · 2006 · 78 · 831310.1021/ac0613582 ↗
21. Demers L. M. · Anal. Chem. (Washington, DC, U. S.) · 2000 · 72 · 553510.1021/ac0006627 ↗
22. Barnes K. R. · Chem. Biol. · 2004 · 11 · 55710.1016/j.chembiol.2004.03.024 ↗
23. Yang J. · Biomaterials · 2011 · 32 · 913610.1016/j.biomaterials.2011.08.022 ↗
24. Jana N. R. · J. Phys. Chem. B · 2001 · 105 · 406510.1021/jp0107964 ↗
25. Dhar S. · J. Am. Chem. Soc. · 2009 · 131 · 1465210.1021/ja9071282 ↗
26. Wang S. · Bioconjugate Chem. · 1996 · 7 · 5610.1021/bc9500709 ↗
27. Martínez R. · Curr. Med. Chem. · 2005 · 12 · 12710.2174/0929867053363414 ↗
28. Ihmels H. · Top. Curr. Chem. · 2005 · 258 · 16110.1007/b135804 ↗
29. Cashman D. J. · Nucleic Acids Res. · 2003 · 31 · 441010.1093/nar/gkg645 ↗
30. Huschka R. · J. Am. Chem. Soc. · 2011 · 133 · 1224710.1021/ja204578e ↗
31. Santra S. · ACS Nano · 2012 · 6 · 728110.1021/nn302393e ↗
32. Kuo W. S. · Chem. Commun. · 2009 · 45 · 485310.1039/b907274h ↗
33. Hauck T. S. · Adv. Mater. · 2008 · 20 · 383210.1002/adma.200800921 ↗
34. Hahn G. M. · Proc. Natl. Acad. Sci. U. S. A. · 1975 · 72 · 93710.1073/pnas.72.3.937 ↗
35. Liu H. Y. · Angew. Chem., Int. Ed. · 2011 · 50 · 89110.1002/anie.201002820 ↗
36. Lee S. M. · Adv. Mater. · 2010 · 22 · 404910.1002/adma.201001040 ↗
37. Bull J. M. C. · Cancer Res. · 1984 · 44 · 4853
38. Palzer R. J. · Cancer Res. · 1973 · 33 · 422